Q. In the below picture which form of solid solution of griseofulvin with succinic acid is shown?

View solution

Q. In the below picture which form of solid solution of griseofulvin with succinic acid is shown?

View solution

Q. Find out the correct option for the marked place in the given picture of the rate of excretion versus midpoint time of urine collection period curve.

View solution

Q. Find out the correct option for the marked place in the given picture of the rate of excretion versus midpoint time of urine collection period curve.

View solution

Q. In the given picture, which kinetic order the graph is following at the marked place?

View solution

Q. In the given picture, which kinetic order the graph is following at the marked place?

View solution

Q. In the given picture, which kinetic order the graph is following at the marked place?

View solution

Q. Which equation plot is being shown in the picture?

View solution

Q. In the given picture, the marking “b” represents the drug concentration of which compartment?

View solution

Q. In the given picture, the marking “a” represents the drug concentration of which compartment?

View solution

Q. At which of the four marked points of the plasma drug concentration versus time graph, absorption rate = elimination rate?

View solution

Q. Which of the following is used in molecular encapsulation of drugs for enhancing bioavailability?

View solution

Q. Which of the following is used in solid solutions method of enhancing bioavailability?

View solution

Q. Which of the following is used in the solvent deposition method of enhancing bioavailability?

View solution

Q. Which one of the following is used for selective adsorption on insoluble carriers of the drugs?

View solution

Q. How pH alteration of the drug microenvironment is done?

View solution

Q. Salts improve solubility and dissolution characteristics.

View solution

Q. What is the principle behind the use of surfactants?

View solution

Q. What will be the particle size after micronization of drugs?

View solution

Q. Which of the following is not an approach for overcoming bioavailability problems?

View solution